Patent · US Active

Inhibitors of JAK

US8853230B2 · kind B2 · utility

18Cited by
7References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2012
Grant dateOct 7, 2014
Priority date
Expiry dateDec 17, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to compounds of formula I and tautomers and pharmaceutically acceptable salts thereof which are selective inhibitors of JAK. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition JAK activity, and methods to prevent or treat a number of conditions mediated at least in part by JAK activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.